Clinical trial
Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or…
NCT00061958 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00061958 |
|---|---|
| Title | Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction |
| Official title | A Phase II Study of Arsenic Trioxide (NSC 706363) in Patients With Advanced Adenocarcinoma of the Esophagus or Gastroesophageal Junction |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Esophagus, Stage III Esophageal Cancer, Stage IV Esophageal Cancer |
| Intervention type | Drug |
| Interventions | arsenic trioxide |
| Enrollment | 50 |
| Start date | Jun 1, 2003 |
| Primary completion | Apr 1, 2005 |
| First posted | Jun 6, 2003 |
| Last update posted | Jan 23, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: